Retrophin

^{Priced, Nasdaq: RTRX}

Developing treatments for postpartum milk let-down, Schizophrenia and Autism.

Industry: Health Care

First Day Return: +35.2%

RTRX

Developing treatments for postpartum milk let-down, Schizophrenia and Autism.

IPO News for Retrophin

Biotech Retrophin sets terms for $40 million NASDAQ listing 01/07/14
US IPO Recap: AMC Entertainment's IPO caps a blockbuster year 12/20/13
Biotech Retrophin files for a $40 million IPO 12/18/13

IPO Data
IPO Date	01/09/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$40
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.retrophin.com
Headquarters	New York, NY, United States
Founded	2008
Employees at IPO	22

IPO News for Retrophin

Biotech Retrophin sets terms for $40 million NASDAQ listing 01/07/14
US IPO Recap: AMC Entertainment's IPO caps a blockbuster year 12/20/13
Biotech Retrophin files for a $40 million IPO 12/18/13

Retrophin (RTRX) Performance